Displaying 1 - 11 of 11

Display:

12 24 48

Metabolism, Alcohol & Toxicity

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)

Webcasts

View

Metabolism, Alcohol & Toxicity

Wrap-up

Webcasts

View

Metabolism, Alcohol & Toxicity

Introduction

Webcasts

View

Metabolism, Alcohol & Toxicity

Q&A

Webcasts

View

Metabolism, Alcohol & Toxicity

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts

View

Metabolism, Alcohol & Toxicity

Clinical cases presentation and discussion

Webcasts

View

Metabolism, Alcohol & Toxicity

FAST score for identification of active fibrotic NASH

Webcasts

View

Metabolism, Alcohol & Toxicity

The NASH care pathway: Drivers and emerging trends

Webcasts

View

Metabolism, Alcohol & Toxicity

How to optimise NASH patient care? – Collaboration with different specialities

Webcasts

View

Metabolism, Alcohol & Toxicity

How do non-invasive techniques improve patient identification and risk stratification?

Webcasts

View

Metabolism, Alcohol & Toxicity

Future improvements needed for care pathways for patients with NASH – Q&A

Webcasts

View

Displaying 1 - 11 of 11

Display:

12 24 48